A Randomized Controlled Open Clinical Study to Evaluate the Efficacy of Nagara Ksheera Nasya in the Management of Ardhavabhedaka with Special Reference to Migraine

Authors

  • Sapna kumari vishwas Rishikul Campus, U.A.U., Haridwar
  • K K Sharma
  • Alok Kumar Srivastava

Keywords:

Migraine, Neurovascular, Shiro-Roga, Ardhavabhedaka, Nasya Karma.

Abstract

Background: One of the 11 forms of Shiro-Roga is called Ardhavabhedaka, and symptomatically similar to Migraine, which is a neurovascular disorder. Panchakarma procedures and many formulations are described in Ayurveda for the management of Ardhavabhedaka. Since Acharya Chakradatta described Nagara-Ksheera Nasya Karma in the context of Shiro-Roga- Chikitsa, an An effort has been made to assess the efficacy of using it for the management of Ardhavabhedaka. Objective Assess the effectiveness of Nagara-Ksheera Nasya as a treatment method for Ardhavabhedaka (Migraine). Materials & Methods: With approval from the Institutional Ethics The study enrolled 40 patients who exhibited clinical symptoms of the condition under investigation of migraine and between the age group of 20 to 50 years irrespective to gender and randomly The patients were divided into two groups of 20 each, labeled Group-A and Group-B. Group-A received the treatment with Nagara Ksheera Nasya (which completed in 3-sittings, each sitting includes 7-days with 7-days interval in between the sittings) and Group-B was treated with control drug (Valproic acid tablets; in the dose of 06-20 mg/kg of body weight, after meal for 42 days), for the estimation of therapy and analyzed effect of Nagara-Ksheera Nasya. The treatment lasted for 42 days in total, which included a 30-day follow- up period. Results: Group A had a better overall impact than Group B. In Group A, 35.29% of patients showed a strong improvement, 41.17% showed a moderate improvement, and 23.52% showed a mild improvement. Conclusion: Nagara-Ksheera Nasya has been shows better results than control drug on almost all the symptoms of migraine, thus it is highly effective in the management of the Ardhavabhedaka w.s.r. to Migraine. Clinical trial registration number: CTRI/2019/03/018113

Author Biography

  • Sapna kumari vishwas, Rishikul Campus, U.A.U., Haridwar
    M.D. Scholar, Department of Panchakarma

References

Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine, 19e. New York, NY, USA: Mcgraw-hill; 2015.

Search results. (2023). from Who.int website: https://www.who.int/home/search indexCatalogue genericsearchindex1&searchQuery=headache %20disorders&wordsMode=AnyWord

Khoury CK, Couch JR. Sumatriptan–naproxen fixed combination for acute treatment of migraine: a critical appraisal. Drug design, development and therapy. 2010 Feb 18:9-17.

Sharma PV. Chakradatta, Sanskrit Text with English Translation. Chaukhamba Publishers, Varanasi. 2002; 56:12.

Tripathi, K. D. Essentials of medical pharmacology. JP Medical Ltd, 2013.

Arnold M. Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia. 2018;38(1):1-211.

Dasji SG. Bhaisajyaratnavali. InChaukhamba Sanskrit Samsthan, Varanasi 2008 (Vol. 1, p. 737).

Vishwas SK, Gupta S, Rani P, Sharma P. Role of Panchakarma in the management of Migraine (Ardhavabhedaka): A Review. Journal of Ayurveda and Integrated Medical Sciences. 2019 Aug 31;4(04):270-4.

Patel, Miral Dharmendra kumar. A comparative study on the efficacy of kumkuma nasya and go-ghrita nasya in the management of ardhavabhedaka with special reference to migraine. Diss. Parul University, 2019.

Joshi JR, Desai S. A randomized clinical trial in the management of Ardhavabhedaka to review the principle- “Nasa Hi Shiraso Dwaram”. Journal of Ayurveda and Integrated Medical Sciences. 2019Jun 30;4(05):100-6.

Downloads

Published

2023-05-13

Issue

Vol. 10 No. 1 (2023)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.